A new set of real-world data from the 3D mammogram developer iCAD showed that its artificial intelligence-powered screening programs were able to increase breast cancer detection rates and help cut | iCAD’s ProFound program was one of the first pieces of AI cleared by the FDA for 3D mammography, an imaging method also referred to as digital breast tomosynthesis or DBT.
Source: iCAD’s AI catches breast cancers in real-world study | FierceBiotech
